219 related articles for article (PubMed ID: 23349715)
21. Liver X receptor agonist treatment significantly affects phenotype and transcriptome of APOE3 and APOE4 Abca1 haplo-deficient mice.
Carter AY; Letronne F; Fitz NF; Mounier A; Wolfe CM; Nam KN; Reeves VL; Kamboh H; Lefterov I; Koldamova R
PLoS One; 2017; 12(2):e0172161. PubMed ID: 28241068
[TBL] [Abstract][Full Text] [Related]
22. Reversal of apoE4-driven brain pathology and behavioral deficits by bexarotene.
Boehm-Cagan A; Michaelson DM
J Neurosci; 2014 May; 34(21):7293-301. PubMed ID: 24849361
[TBL] [Abstract][Full Text] [Related]
23. Suppression of chronic damage in renal allografts by Liver X receptor (LXR) activation relevant contribution of macrophage LXRα.
Kiss E; Popovic Z; Bedke J; Wang S; Bonrouhi M; Gretz N; Stettner P; Teupser D; Thiery J; Porubsky S; Adams J; Gröne HJ
Am J Pathol; 2011 Jul; 179(1):92-103. PubMed ID: 21703396
[TBL] [Abstract][Full Text] [Related]
24. Pharmacological activation of liver X receptors promotes reverse cholesterol transport in vivo.
Naik SU; Wang X; Da Silva JS; Jaye M; Macphee CH; Reilly MP; Billheimer JT; Rothblat GH; Rader DJ
Circulation; 2006 Jan; 113(1):90-7. PubMed ID: 16365197
[TBL] [Abstract][Full Text] [Related]
25. Liver X Receptor Agonist Modifies the DNA Methylation Profile of Synapse and Neurogenesis-Related Genes in the Triple Transgenic Mouse Model of Alzheimer's Disease.
Sandoval-Hernández AG; Hernández HG; Restrepo A; Muñoz JI; Bayon GF; Fernández AF; Fraga MF; Cardona-Gómez GP; Arboleda H; Arboleda GH
J Mol Neurosci; 2016 Feb; 58(2):243-53. PubMed ID: 26553261
[TBL] [Abstract][Full Text] [Related]
26. Tissue-specific liver X receptor activation promotes macrophage reverse cholesterol transport in vivo.
Yasuda T; Grillot D; Billheimer JT; Briand F; Delerive P; Huet S; Rader DJ
Arterioscler Thromb Vasc Biol; 2010 Apr; 30(4):781-6. PubMed ID: 20110577
[TBL] [Abstract][Full Text] [Related]
27. Liver X receptor agonist GW3965 dose-dependently regulates lps-mediated liver injury and modulates posttranscriptional TNF-alpha production and p38 mitogen-activated protein kinase activation in liver macrophages.
Wang YY; Dahle MK; Steffensen KR; Reinholt FP; Collins JL; Thiemermann C; Aasen AO; Gustafsson JA; Wang JE
Shock; 2009 Nov; 32(5):548-53. PubMed ID: 19295476
[TBL] [Abstract][Full Text] [Related]
28. ABCA1 is Necessary for Bexarotene-Mediated Clearance of Soluble Amyloid Beta from the Hippocampus of APP/PS1 Mice.
Corona AW; Kodoma N; Casali BT; Landreth GE
J Neuroimmune Pharmacol; 2016 Mar; 11(1):61-72. PubMed ID: 26175148
[TBL] [Abstract][Full Text] [Related]
29. Identification of a Chrysanthemic Ester as an Apolipoprotein E Inducer in Astrocytes.
Fan J; Zareyan S; Zhao W; Shimizu Y; Pfeifer TA; Tak JH; Isman MB; Van den Hoven B; Duggan ME; Wood MW; Wellington CL; Kulic I
PLoS One; 2016; 11(9):e0162384. PubMed ID: 27598782
[TBL] [Abstract][Full Text] [Related]
30. Activation of Liver X receptors in the heart leads to accumulation of intracellular lipids and attenuation of ischemia-reperfusion injury.
Lei P; Baysa A; Nebb HI; Valen G; Skomedal T; Osnes JB; Yang Z; Haugen F
Basic Res Cardiol; 2013 Jan; 108(1):323. PubMed ID: 23266787
[TBL] [Abstract][Full Text] [Related]
31. Activation of liver X receptor reduces global ischemic brain injury by reduction of nuclear factor-kappaB.
Cheng O; Ostrowski RP; Liu W; Zhang JH
Neuroscience; 2010 Apr; 166(4):1101-9. PubMed ID: 20096333
[TBL] [Abstract][Full Text] [Related]
32. Fasting-induced FGF21 is repressed by LXR activation via recruitment of an HDAC3 corepressor complex in mice.
Archer A; Venteclef N; Mode A; Pedrelli M; Gabbi C; Clément K; Parini P; Gustafsson JÅ; Korach-André M
Mol Endocrinol; 2012 Dec; 26(12):1980-90. PubMed ID: 23073827
[TBL] [Abstract][Full Text] [Related]
33. Raising HDL cholesterol without inducing hepatic steatosis and hypertriglyceridemia by a selective LXR modulator.
Miao B; Zondlo S; Gibbs S; Cromley D; Hosagrahara VP; Kirchgessner TG; Billheimer J; Mukherjee R
J Lipid Res; 2004 Aug; 45(8):1410-7. PubMed ID: 15145986
[TBL] [Abstract][Full Text] [Related]
34. Tissue-specific induction of intestinal ABCA1 expression with a liver X receptor agonist raises plasma HDL cholesterol levels.
Brunham LR; Kruit JK; Pape TD; Parks JS; Kuipers F; Hayden MR
Circ Res; 2006 Sep; 99(7):672-4. PubMed ID: 16946132
[TBL] [Abstract][Full Text] [Related]
35. GW3965, a synthetic liver X receptor (LXR) agonist, reduces angiotensin II-mediated pressor responses in Sprague-Dawley rats.
Leik CE; Carson NL; Hennan JK; Basso MD; Liu QY; Crandall DL; Nambi P
Br J Pharmacol; 2007 Jun; 151(4):450-6. PubMed ID: 17420776
[TBL] [Abstract][Full Text] [Related]
36. Mechanisms underlying the rapid peroxisome proliferator-activated receptor-γ-mediated amyloid clearance and reversal of cognitive deficits in a murine model of Alzheimer's disease.
Mandrekar-Colucci S; Karlo JC; Landreth GE
J Neurosci; 2012 Jul; 32(30):10117-28. PubMed ID: 22836247
[TBL] [Abstract][Full Text] [Related]
37. Niemann-Pick C1-like 1 is required for an LXR agonist to raise plasma HDL cholesterol in mice.
Tang W; Ma Y; Jia L; Ioannou YA; Davies JP; Yu L
Arterioscler Thromb Vasc Biol; 2008 Mar; 28(3):448-54. PubMed ID: 18187667
[TBL] [Abstract][Full Text] [Related]
38. Liver X receptor agonist treatment attenuates cardiac dysfunction in type 2 diabetic db/db mice.
He Q; Pu J; Yuan A; Yao T; Ying X; Zhao Y; Xu L; Tong H; He B
Cardiovasc Diabetol; 2014 Nov; 13():149. PubMed ID: 25416469
[TBL] [Abstract][Full Text] [Related]
39. Enhanced liver X receptor signalling reduces brain injury and promotes tissue regeneration following experimental intracerebral haemorrhage: roles of microglia/macrophages.
Zhang R; Dong Y; Liu Y; Moezzi D; Ghorbani S; Mirzaei R; Lozinski BM; Dunn JF; Yong VW; Xue M
Stroke Vasc Neurol; 2023 Dec; 8(6):486-502. PubMed ID: 37137522
[TBL] [Abstract][Full Text] [Related]
40. [Expression of LXR-β in human gastric cancer tissue and the effect of GW3965 on the proliferation of gastric cancer cell line SGC-7901].
Wang R; Li R; Wen Q; Peng K; Tan X; Chen Z
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2016 Feb; 41(2):127-33. PubMed ID: 26932209
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
